High materiality7/10
Abivax price target raised to $155 from $135 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist raises Abivax target to $155 from $135; current price is $132.56, implying upside.
- Target: $155 (up from $135)
- Posted price: $132.56
- Analyst: Truist Financial
Key facts
- 01
Target: $155
- 02
Posted price: $132.56
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.